Napo Pharmaceuticals, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
7
Ending by 2030
Feb 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 22, 2027The maintenance fee for Method for treatment of constipation-predominant irritable bowel syndrome (US 9,138,450) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
- 1 fee due Apr 10, 2027The maintenance fee for Methods and compositions for treating bile acid diarrhea, diarrhea associated with small intestine resection or gallbladder removal, and short bowel syndrome (US 11,779,564) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
- 1 fee due Jun 1, 2027The maintenance fee for Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA) (US 9,198,879) comes due Jun 1, 2027. Unpaid by Dec 1, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Methods and Compositions for Treating Congenital Diarrhea Disorder (US 11,857,510) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Oct 19, 2027The maintenance fee for Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA) (US 9,314,437) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,113 | Method for treatment of diarrhea-predominant irritable bowel syndrome In force · From the USPTO record | In force | From the USPTO record | |
| US 9,980,938 | Method for treatment of diarrhea-predominant irritable bowel syndrome In force · From the USPTO record | In force | From the USPTO record | |
| US 8,067,041 | Method for treatment of constipation-predominant irritable bowel syndrome In force · From the USPTO record | In force | From the USPTO record | |
| US 7,556,831 | Method for treatment of constipation-predominant irritable bowel syndrome In force · From the USPTO record | In force | From the USPTO record | |
| US 9,987,250 | Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 9,138,450 | Method for treatment of constipation-predominant irritable bowel syndrome In force · From the USPTO record | In force | From the USPTO record | |
| US 8,852,649 | Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer In force · From the USPTO record | In force | From the USPTO record | |
| US 8,962,680 | Methods and Compositions for Treating HIV-Associated Diarrhea In force · Medium confidence | In force | Medium confidence | |
| US 9,585,868 | Methods and Compositions for Treating HIV-Associated Diarrhea In force · Medium confidence | In force | Medium confidence | |
| US 9,198,879 | Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (NDGA) In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record |
Also on record, not counted in the 14: 5 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 1 abandoned · 2 no status recorded